SecProbe.io - Probe Score Transparency

Probe Score Transparency

Spyre Therapeutics, Inc. (SYRE)
Score window: May. 30, 2025 to May. 29, 2026

Back View Correspondence

Probe Score

3.5 / 10

Letters

2

Latest Activity

Jun. 2, 2025

Version

v1

Score Breakdown

Letter Count

2.0

Sentiment / Tone

1.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

0.0

Notable 8-K Count

0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
Feb. 25, 2026	UPLOAD	Neutral/Informational	Low	The SEC has communicated to Spyre Therapeutics, Inc. that it will not review their registration statement filed on February 19, 2026. The letter emphasizes that the responsibility…	Read Filing EDGAR
Feb. 25, 2026	CORRESP	Neutral/Informational	Moderate	Spyre Therapeutics, Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-3. The company seeks to have the reg…	Read Filing EDGAR
Jun. 2, 2025	UPLOAD	Neutral/Informational	Low	The SEC has completed its review of Spyre Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes that the responsibility for the…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.